Early-stage biotech investment: where are we?
Drug Discovery World
JUNE 17, 2024
It is well recognised by both investors and government that the UK has huge strengths in biotechnology. Our corporate finance team have seen some biotech companies with outstanding potential that is poorly packaged from an investment point of view – getting this right is worth its weight in gold (literally!).
Let's personalize your content